New study aims to spot muscle decline in cancer patients early
NCT ID NCT07387770
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will track muscle deterioration in about 40 hospitalized cancer patients using simple tests like grip strength, electrical muscle readings, and body composition scans. Researchers hope to find patterns that help identify muscle loss early, which could lead to better support and treatment. No new drugs or treatments are being tested—this is purely an observation study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to detect muscle loss early in cancer patients, helping doctors intervene sooner to improve outcomes.
- What could go wrong
- This is an observational study with only 40 participants, so results may not apply to all cancer patients. It does not test a treatment, so direct benefits are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGIC DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home workouts for cancer recovery: a new trial tests feasibility
- New program aims to break the silence on palliative care for cancer patients
- Painkiller-blood thinner combo under scrutiny in cancer patients
- Martinique hospital probes low cancer trial participation
- Radiation's hidden cost: new study tracks financial toxicity in cancer patients